Medicament for treating glaucoma comprising as an active ingredient cyclodextrin-clathrate compound of cilostazol
US8686001B2 · kind B2 · utility
0Cited by
0References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 1, 2008 |
| Grant date | Apr 1, 2014 |
| Priority date | — |
| Expiry date | Apr 16, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC08L5/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to an ophthalmic medicament for treating glaucoma which comprises a clathrate compound prepared by dissolving cilostazol or a salt thereof in a cyclodextrin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.